MHRA trials innovative AI technologies to consider regulatory approach
The MHRA is looking at five technologies in its AI Airlock pilot scheme, looking to inform its regulatory approach.
Corporate Governance
RFK’s regulatory plans could overburden small manufacturers, says analyst
Dr Oz nominated to lead CMS despite big pharma ties
Trump 2.0 spells uncertainty for US healthcare, says analyst
US maternal care failings due to ‘focus on reactive care’
FDA’s final rule on LDTs causes concern, but timeline looks unsteady
Reeves’ 2024 budget promises life sciences investment
US senators raise Pfizer and Eli Lilly telehealth prescribing concerns
